0001225208-19-010843.txt : 20190805 0001225208-19-010843.hdr.sgml : 20190805 20190805160747 ACCESSION NUMBER: 0001225208-19-010843 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190802 FILED AS OF DATE: 20190805 DATE AS OF CHANGE: 20190805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pierce David A CENTRAL INDEX KEY: 0001529751 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 19998684 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2019-08-02 0000885725 BOSTON SCIENTIFIC CORP BSX 0001529751 Pierce David A 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP,Pres MedSurg Common Stock 2019-08-02 4 M 0 5000.0000 6.2800 A 29201.0000 D Common Stock 2019-08-02 4 S 0 5000.0000 42.6183 D 24201.0000 D Stock Option (Right to Buy) 6.2800 2019-08-02 4 M 0 5000.0000 0.0000 D 2022-02-27 Common Stock 5000.0000 24997.0000 D This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.685, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. /s/ Scott G. Hodgdon, Attorney-in-Fact 2019-08-05